Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Non-Current Deferred Tax Liability (2017 - 2025)

Historic Non-Current Deferred Tax Liability for Lineage Cell Therapeutics (LCTX) over the last 11 years, with Q3 2025 value amounting to $273000.0.

  • Lineage Cell Therapeutics' Non-Current Deferred Tax Liability changed 0.0% to $273000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $273000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $273000.0 for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Lineage Cell Therapeutics reported Non-Current Deferred Tax Liability of $273000.0 as of Q3 2025, which was down 0.0% from $273000.0 recorded in Q2 2025.
  • In the past 5 years, Lineage Cell Therapeutics' Non-Current Deferred Tax Liability registered a high of $2.1 million during Q1 2021, and its lowest value of $273000.0 during Q1 2023.
  • Over the past 5 years, Lineage Cell Therapeutics' median Non-Current Deferred Tax Liability value was $273000.0 (recorded in 2023), while the average stood at $961052.6.
  • Per our database at Business Quant, Lineage Cell Therapeutics' Non-Current Deferred Tax Liability soared by 13221.48% in 2022 and then crashed by 8684.97% in 2023.
  • Lineage Cell Therapeutics' Non-Current Deferred Tax Liability (Quarter) stood at $2.1 million in 2021, then changed by 0.0% to $2.1 million in 2022, then plummeted by 86.85% to $273000.0 in 2023, then changed by 0.0% to $273000.0 in 2024, then changed by 0.0% to $273000.0 in 2025.
  • Its Non-Current Deferred Tax Liability was $273000.0 in Q3 2025, compared to $273000.0 in Q2 2025 and $273000.0 in Q1 2025.